For how we live.
Italy logged 296 locally acquired cases in 2024, a European record. Transmission rose 19.8% per 1°C of warming, and modelling puts most of France in range for the mosquito that carries it this century.
A cluster-randomised trial in Cúcuta coated water containers in 13,803 homes. Dengue incidence fell to 337 per 100,000 versus 528 in control clusters, at about US$2 per household a year.
A peer-reviewed account traces the mass screening and tsetse-fly control that cut gambiense sleeping sickness below one case per 10,000 in endemic areas — the threshold WHO validated in January 2025.
A CDC surveillance summary puts 2024 at 359% above the 2010–2023 annual average. The 2.8% that were locally acquired are the part that changes what mosquito control has to plan for.
The surveillance behind the WHO-verified milestone is now published: no infective blackflies at any monitored site, and no infection among 16,406 children tested.
A cluster-randomised trial across 15 population clusters found mosquito abundance collapsed in intervention areas and protective efficacy of 71–72% against symptomatic dengue.
The agency stops short of calling 2025 a global surge. Its own regional tables show why: the Americas and the Indian Ocean drove the total while the Philippines and Malaysia reported fewer cases than last year.
In a 400-pair trial in Uganda where every family already had a bed net, insecticide-treated wraps reduced clinical malaria in infants from 2.14 to 0.73 cases per 100 person-weeks.